UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preventing disease progression in multiple sclerosis-insights from large real-world cohorts

Genome medicine, 2022-04, Vol.14 (1), p.41-41, Article 41

2022

Volltextzugriff (PDF)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211051497-17562864211051497

2021

Volltextzugriff (PDF)

Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231170928-17562864231170928

2023

Volltextzugriff (PDF)

PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders

Therapeutic advances in neurological disorders, 2020-01, Vol.13, p.1756286419895155

2020

Volltextzugriff (PDF)

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension

Fluids and barriers of the CNS, 2023-01, Vol.20 (1), p.3-3, Article 3

2023

Volltextzugriff (PDF)

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

EBioMedicine, 2021-10, Vol.72, p.103590-103590, Article 103590

2021

Volltextzugriff (PDF)

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211001977-17562864211001977

2021

Volltextzugriff (PDF)

A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors

Journal of central nervous system disease, 2021-08, Vol.13, p.11795735211037798

2021

Volltextzugriff (PDF)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis

Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00419-e00419

2021

Volltextzugriff (PDF)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis

JHEP reports, 2023-04, Vol.5 (4), p.100671-100671, Article 100671

2023

Volltextzugriff (PDF)

Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis

JAAD Case Reports, 2022-10, Vol.28, p.24-27

2022

Volltextzugriff (PDF)

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Neurological research and practice, 2022-11, Vol.4 (1), p.55-55, Article 55

2022

Volltextzugriff (PDF)

Infektionen unter Immuntherapie zur Behandlung der multiplen Sklerose

DGNeurologie, 2018-09, Vol.1 (1), p.7-10

2018

Volltextzugriff (PDF)

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS

Neurology : neuroimmunology & neuroinflammation, 2018-09, Vol.5 (5), p.e481-e481

2018

Volltextzugriff (PDF)

The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosis

Autoimmunity reviews, 2021-05, Vol.20 (5), p.102802, Article 102802

2021

Volltextzugriff (PDF)

Electrophysiological parameters as biomarkers for psychiatry: Intra-individual variability and influencing factors

International journal of psychophysiology, 2018-01, Vol.123, p.42-47

2018

Volltextzugriff (PDF)

Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS

Neurology : neuroimmunology & neuroinflammation, 2020-05, Vol.7 (3), p.e679-e679

2020

Volltextzugriff (PDF)

B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans

Science translational medicine, 2024-03, Vol.16 (737)

2024

Volltextzugriff (PDF)

Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases

Journal of clinical apheresis, 2022-02, Vol.37 (1), p.70-81

2022

Volltextzugriff (PDF)

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression

EBioMedicine, 2021-10, Vol.72

2021

Volltextzugriff (PDF)

Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort

Neurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1)

2023

Volltextzugriff (PDF)

Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS

Neurology : neuroimmunology & neuroinflammation, 2019-09, Vol.6 (5)

2019

Volltextzugriff (PDF)

Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS

Neurology : neuroimmunology & neuroinflammation, 2021-01, Vol.8 (1)

2021

Volltextzugriff (PDF)

Laquinimod dampens IL-1beta signaling and Th17-polarizing capacity of monocytes in patients with MS

Neurology : neuroimmunology & neuroinflammation, 2021, Vol.8 (1)

2021

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(27)
Berichte
(3)

Sprache

Englisch
(28)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preventing disease progression in multiple sclerosis-insights from large real-world cohorts

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus

Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial

PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis

A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis

Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Infektionen unter Immuntherapie zur Behandlung der multiplen Sklerose

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosis

Electrophysiological parameters as biomarkers for psychiatry: Intra-individual variability and influencing factors

Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS

B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans

Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression

Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort

Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS

Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS

Laquinimod dampens IL-1beta signaling and Th17-polarizing capacity of monocytes in patients with MS

Suchergebnisse filtern